- Replimune Group Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Replimune Group Inc RP1 Program Update Call TranscriptDec 05, 2023
- Replimune Group Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Replimune Group Inc to Host Virtual Investor Event TranscriptDec 07, 2022
- Replimune Group Inc To Host Investor Day TranscriptMar 30, 2022
- Replimune Group Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Replimune Group Inc Annual Shareholders Meeting TranscriptSep 08, 2021
- Replimune Group Inc Virtual Investor Event Corporate Call TranscriptJun 03, 2021
- Replimune Group Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Replimune Group Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Replimune Group Inc to Provide Phase 1/2 Clinical Data Update on Patients with Melanoma and Non-Melanoma Skin Cancers - Conference Call TranscriptJun 03, 2020
- Replimune Group Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
Replimune Group Inc Virtual Investor Event Corporate Call Transcript
Good morning, and thank you for joining our midyear data update event. And before we begin, I need to highlight our forward-looking statement on Slide 2. I'm Philip Astley-Sparke, CEO of Replimune. And I have with me today, Dr. Robert Coffin, our President and Chief R&D Officer; we also have Dr. Mark Middleton, Professor of Experimental Cancer Medicine and Consultant Medical Oncologist at the Oxford Cancer Center and the Head of the Department of Oncology at the University of Oxford.
Slide 3 shows the agenda for the call, which will start with a brief [berth] introduction from me and a brief summary of the high level updated results by Rob, followed by discussion of the results in number of the individual patients by Dr. Middleton. Rob will then provide an overview of what will be one strand of our future development efforts with RP2, 3.
Following the presentation, we'll be holding a live Q&A. To ask a question, please type your question and click submit in the Q&A section on the bottom of your
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)